Evidence map›Paper›PMID 41786887›Full record

ArticleNature cell biology2026

N

Ji Hoon Lee, Mark Tingey, Zhao Zhang, Florian Buerger, Juyeong Hong, Guanshi Zhang, Mei Yang, Baowen Du, Ji-Hoon Jeong, Kayode A John and 8 more

Abstract read
In one paragraph

Article in Nature cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Ji Hoon Lee *Department of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX, USA. Leej23@uthscsa.edu.ORCID http://orcid.org/0000-0002-7488-3999
Mark Tingey *Department of Biology, Temple University, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-0365-5585
Zhao Zhang *Department of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX, USA.ORCID http://orcid.org/0000-0002-3679-8945
Florian BuergerDepartment of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-2655-387X
Juyeong HongDepartment of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX, USA.
Guanshi ZhangCenter for Precision Medicine, Division of Nephrology, Department of Medicine, University of Texas Health San Antonio, San Antonio, TX, USA.ORCID http://orcid.org/0000-0001-6557-4521
Mei YangDepartment of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX, USA.
Baowen DuDepartment of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX, USA.
Ji-Hoon JeongDepartment of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX, USA.ORCID http://orcid.org/0000-0002-2404-6850
Kayode A JohnDepartment of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX, USA.
Ian M TamayoCenter for Precision Medicine, Division of Nephrology, Department of Medicine, University of Texas Health San Antonio, San Antonio, TX, USA.
Qingwei D ZhaoCenter for Precision Medicine, Division of Nephrology, Department of Medicine, University of Texas Health San Antonio, San Antonio, TX, USA.
Friedhelm HildebrandtDepartment of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7130-0030
Marina ĐurišićLaboratory of Medical Genetics, The Institute for Health Care of Mother and Child of Serbia 'Dr Vukan Čupić', Belgrade, Serbia.
Nataša StajićInstitute for Mother and Child Health Care of Serbia 'Dr Vukan Čupić', Department of Nephrology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Brankica SpasojevićUniversity Children's Hospital, Department of Nephrology, University of Belgrade, Faculty of Medicine, Belgrade, Serbia.
Weidong YangDepartment of Biology, Temple University, Philadelphia, PA, USA. Weidong.Yang@temple.edu.ORCID http://orcid.org/0000-0002-3649-1863
Kexin XuDepartment of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX, USA. xtx3wj@virginia.edu.ORCID http://orcid.org/0000-0002-2850-2083

Funding

Super-resolution Microscopy Study of Molecular Transport MechanismsR35GM122552 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI Weidong Yang · 2017 to 2026
$4.5M
METTL3-NUP93 interaction facilitates the nuclear export of m6A-modified mRNAsR01GM140084 · NIGMS · UNIVERSITY OF VIRGINIA · PI XU, KEXIN · 2021 to 2025
$1.7M
The role and mechanism of RNA m6A modification in the pathogenesis and drug-resistance of prostate cancerR01CA279696 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Jihoon Lee · 2023 to 2026
$1.5M
NIGMS NIH HHS R35 GM122552U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA279696U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R01GM140084U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM122552
6 · The paper itself

Abstract

Nuclear export of messenger RNAs (mRNAs) through nuclear pore complexes (NPCs) is a critical step in gene expression. Although N

Indexed as

AdenosineCell NucleusMethyltransferasesNuclear Pore Complex ProteinsRNA, MessengerActive Transport, Cell NucleusAnimalsEpitranscriptomeHEK293 CellsHeLa CellsHumansMethylationRNA MethylationAdenosineMethyltransferasesMETTL3 protein, humanN-methyladenosineNuclear Pore Complex ProteinsNup93 protein, humanRNA, Messenger

Identifiers

PMID41786887
PMCPMC13122486

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.